A common method for modeling pathological and behavioral aspects of Alzheimer's disease (AD) is the transgenic mouse. While transgenic strains are often well characterized pathologically, behavioral studies of cognitive deficits often employ a limited set of aversively motivated, spatial learning and memory tests, under brief testing periods. Here we illustrate an alternative operant behavioral methodology to provide a comprehensive characterization under repetitive testing conditions, and with appetitive motivation. In this study, we employed the commonly used Tg2576 murine model of Alzheimer's disease amyloid pathology, since it has been the subject of many previous behavioral studies. In these mice, we compared the learning of simple and complex, as well as spatial and non-spatial rules. The mice were assessed on a progressively more complex and interlocking battery of operant tasks, ranging from simple rule learning to delayed recall, as well as tests of motor and sensory ability. In general, as compared to wild type control mice, within-group variability was high in the Tg2576 mice, and deficits were most apparent in more complex discrimination tasks. Furthermore, a consistent decrease in the rate at which Tg2576 mice completed testing trials was observed, pointing to a potential motivation difference or speed-accuracy tradeoffs as a defining characteristic of this strain under these test conditions. Using sensitive adjusting retention interval procedures, it was also possible to isolate a difference in retention interval and separate it from non-mnemonic processes. Overall, these experiments demonstrate the utility of this novel operant approach for characterizing the cognitive deficits of transgenic murine models of dementia.
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Introduction
Alzheimer's disease (AD) is a progressive, debilitating disease pathologically characterized by amyloid plaques, neurofibrillary tangles and neuronal loss. The disease clinically manifests with memory loss, disorientation, and other behavioral changes (Alzheimer, 1907; Davies & Maloney, 1976; Murrell, Farlow, Ghetti, & Benson, 1991; Price, Walker, Martin, & Sisodie, 1992; Selkoe, 2001 Selkoe, , 2004 . AD has been studied in spontaneous mammalian animal models, including primates and rodents by using lesions of various specificities by using pharmacological challenges such as anticholinergic drugs, and by using aged animals (Bartus, 2000; Sherman, Kuster, Dean, Bartus, & Freidman, 1981) . In the last two decades, transgenic murine lines have become one of the dominant methods for studying the etiology, neuropathology, and treatment strategies for AD (Götz et al., 2007; Iqbal et al., 2005) . Most transgenic mouse lines were created from introducing gene mutations related to familial early-onset forms of AD, alone or in combination, into transgenes encoding human amyloid ß-protein precursor (AßPP) and characterized by the appearance over the lifespan of various histopathological and behavioral abnormalities, particularly learning and memory alterations.
One such well-studied transgenic model is the Tg2576 mouse line, introduced in 1996 by Hsiao et al. which contains the Swedish double mutation (K670N/M671L) under the control of a Hamster PrP promoter. As early as 6 months, but virtually, universally by 12-14 months of age, these mice show substantial accumulations of human Ab species, especially Ab42, congophilic plaques, and inflammation in cortical and limbic structures. While this is one of the most thoroughly studied human AßPP transgenic mouse lines, one important limitation is in the behavioral characterization of this line. There is reliance on tasks such as passive/active avoidance and object recognition, or on spatially intensive learning and memory tests such as spontaneous alternation, the Morris water
